November 20, 2025 — RNews

#chemotherapy — Thursday, November 20, 2025 (1 items)

hot top new

← prev day next day →

0

Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 x 2 factorial phase 3 trial. (linkinghub.elsevier.com)

Reni M … Falconi M The Lancet 2025-11-20

#clinical trial #surgery #chemotherapy #pancreatic cancer #neoadjuvant